Status:

COMPLETED

Efficacy of Prebiotic and Probiotic Dietary Modulation in Schizophrenic Disorders

Lead Sponsor:

Universidad de Córdoba

Collaborating Sponsors:

Castilla-León Health Service

Conditions:

Schizophrenia and Related Disorders

Diet Habit

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The microbiota plays a vital role in the two-way communication between the gastrointestinal tract and the central nervous system (CNS), articulated as the microbiota-intestine-brain axis. This functio...

Detailed Description

1. INTRODUCTION 1.1. Theoretical Framework Schizophrenia is a chronic mental illness characterized by significant clinical heterogeneity and a long evolution over time, determined by periods o...

Eligibility Criteria

Inclusion

  • -Patients diagnosed on the spectrum of schizophrenia (without distinction by type), according to criteria DSM-5 and/or ICD-11.
  • Age between 18-65 years.
  • \- Absence of gastrointestinal comorbidity that contraindicates the use of prebiotics and/or probiotics (intolerance, explosive diarrhea, acute abdominal pain, etc.).
  • -To show clinical stability for six months before the start of the study (absence of psychiatric hospitalization, maintenance of the level of functionality, and lack of social and occupational absenteeism).
  • \- To manifest agreement to participate in the study and to sign of informed consent.

Exclusion

  • -Non-compliance with the inclusion criteria mentioned above.
  • \- To suffer from somatic or neurocognitive situation that prevents participation and collaboration in the fulfillment of the protocol.
  • \- To follow standardized dietary planning not modulated by the population under study (catering, institutional or collective feeding, etc.).
  • -Concomitant administration of antibiotherapy.
  • Refusal to participate in the study.

Key Trial Info

Start Date :

June 25 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 26 2023

Estimated Enrollment :

44 Patients enrolled

Trial Details

Trial ID

NCT04366401

Start Date

June 25 2020

End Date

December 26 2023

Last Update

May 9 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Universidad de Córdoba.

Córdoba, Spain, 14071